(Q58838532)

ORCID Public Data File 2021

author name string

Alan Murphy

series ordinal

1

0 references

publication date

October 1999

0 references

published in

Enzyme and Microbial Technology

0 references

volume

25

0 references

issue

7

0 references

page(s)

551-557

0 references

cites work

Immobilizing proteins on the surface of yeast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Classic Kaposi's sarcoma: low-dose interferon alfa treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Interferon-alpha: evolving therapy for AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Chronic granulomatous disease of childhood: clinical, pathological, biochemical, molecular, and genetic aspects of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Risk assessment of fungi reported from humans and animals

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Brewer's yeast as a cause of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Saccharomyces cerevisiae pneumonia in a patient with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Saccharomyces cerevisiae septicemia in a patient with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Saccharomyces cerevisiae septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Postoperative peritonitis caused by Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Fever of unknown origin secondary to brewer's yeast ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Saccharomyces boulardii is not Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Degradation of humoral host defense by Candida albicans proteinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

High-frequency switching in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Gene regulation during high-frequency switching in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Colony phenotype switching in clinical and non-clinical isolates of Saccharomyces cerevisiae.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Over-expression of Saccharomyces cerevisiae hsp90 enhances the virulence of this yeast in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations?

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Safety of amphotericin B colloidal dispersion

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Mechanism of fluconazole resistance in Candida krusei

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Amphotericin B colloidal dispersion for treatment of candidemia in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Lipid formulations of amphotericin B: recent progress and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Saccharomyces cerevisiae infections and antifungal susceptibility studies by colorimetric and broth macrodilution methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Impact of the changing epidemiology of fungal infections in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Epidemiological shifts in opportunistic and nosocomial Candida infections: mycological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021

Divergent transcriptional control of multidrug resistance genes in Saccharomyces cerevisiae.

1 reference

https://api.crossref.org/works/10.1016%2FS0141-0229%2899%2900086-1

7 January 2021